NFKB1 and Sepsis: DNase-1 coated long-acting nanoparticles have been suggested as a therapeutic intervention to efficiently reduce the accumulation of NETs and the NF-κB-induced cytokine production in a mouse model of sepsis by improving the stability of the enzyme [58].